Marc and Jennifer Lipschultz Precision Immunology Institute

Publications

Recent Featured Publications

2023

SCIENCE IMMUNOLOGY

Sustained CD28 costimulation is required for self-renewal and differentiation of TCF-1+ PD-1+ CD8 T cells

2023-08

Humblin, et al.

READ MORE

 

NATURE NANOTECHNOLOGY

Close the cancer–immunity cycle by integrating lipid nanoparticle–mRNA formulations and dendritic cell therapy

2023-07

Zhang, et al.

READ MORE

 

NATURE MEDICINE

Intratumoral dendritic cell–CD4+ T helper cell niches enable CD8+ T cell differentiation following PD-1 blockade in hepatocellular carcinoma

2023-06

Magen, et al.

READ MORE

 

NATURE IMMUNOLOGY

TREM2 macrophages drive NK cell paucity and dysfunction in lung cancer

2023-04

Park, et al.

READ MORE

 

GASTROENTEROLOGY

Anti-Integrin αvβ6 Autoantibodies Are a Novel Biomarker That Antedate Ulcerative Colitis

2023-04

Livanos, et al.

READ MORE

 

IMMUNITY

Monocytes re-enter the bone marrow during fasting and alter the host response to infection

2023-04

Janssen, et al.

READ MORE

 

NEJM

Phase 2 Trial of Difelikefalin in Notalgia Paresthetica

2023-02

Kim, et al.

READ MORE

 

NATURE

Autoimmunity in Down's syndrome via cytokines, CD4 T cells and CD11+ B cells

2023-02

Malle, et al.

READ MORE

 

2022

BLOOD

Interventions and outcomes of multiple myeloma patients receiving salvage treatment after BCMA-directed CAR T therapy

2022-11

Van Oekelen, et al.

READ MORE

 

IMMUNITY

Immunoglobulin A antibody composition is sculpted to bind the self gut microbiome

2022-11

Malle, et al.

READ MORE

 

SCIENCE TRANSLATIONAL MEDICINE

A shift in lung macrophage composition is associated with COVID-19 severity and recovery

2022-09

Chen, et al.

READ MORE

 

SCIENCE IMMUNOLOGY

Immunoglobulin A antibody composition is sculpted to bind the self gut microbiome

2022-07

Yang, et al.

READ MORE

 

NATURE BIOTECHNOLOGY

Rapid, scalable assessment of SARS-CoV-2 cellular immunity by whole-blood PCR

2022-06

Schwarz, et al.

READ MORE

 

NATURE 

Brain motor and fear circuits regulate leukocytes during acute stress

2022-05

Poller, et al.

READ MORE

 

NATURE MEDICINE

Neoadjuvant clinical trials provide a window of opportunity for cancer discovery

2022-03

Marron, et al.

READ MORE

 

CELL

Spatial CRISPR genomics identifies regulators of the tumor microenvironment

2022-03

Dhainaut, et al.

READ MORE

 

THE LANCET GASTROENTEROLOGY & HEPATOLOGY

Neoadjuvant cemiplimab for resectable hepatocellular carcinoma: a single-arm, open-label, phase 2 trial

2022-03

Marron, et al.

READ MORE

 

NATURE MEDICINE

Ulcerative colitis is characterized by a plasmablast-skewed humoral response associated with disease activity

2022-02

Uzzan, et al.

READ MORE

 

2023

Science Immunology.  Sustained CD28 costimulation is required for self-renewal and differentiation of TCF-1+ PD-1+ CD8 T cells.

Nature Nanotechnology.  Close the cancer-immunity cycle by integrating lipid nanoparticle-mRNA formulations and dendritic cell therapy.

Nature Medicine.  Intratumoral dendritic cell–CD4+ T helper cell niches enable CD8+ T cell differentiation following PD-1 blockade in hepatocellular carcinoma.

Nature Immunology. TREM2 macrophages drive NK cell paucity and dysfunction in lung cancer.

Journal of Clinical Investigation. A paracrine circuit of IL-1β/IL-1R1 between myeloid and tumor cells drives genotype-dependent glioblastoma progression.

Frontiers in Immunology.  Multi-omic analysis of the tumour microenvironment shows clinical correlations in Ph1 study of atezolizumab +/- SoC in MM.

Journal for Immunotherapy of Cancer.  Pattern recognition receptor agonists in pathogen vaccines mediate antitumor T-cell cross-priming.

Blood Advances. The utility of biomarkers in acute GVHD prognostication.

Nature Communications. Monocyte depletion enhances neutrophil influx and proneural to mesenchymal transition in glioblastoma.

BJU International. Urine supernatant reveals a signature that predicts survival in clear-cell renal cell carcinoma.

NPJ Precision Oncology. Germline rare deleterious variant load alters cancer risk, age of onset and tumor characteristics.

Nature Communications. Expanding cross-presenting dendritic cells enhances oncolytic virotherapy and is critical for long-term anti-tumor immunity.

2022

Nature Communications. Expanding cross-presenting dendritic cells enhances oncolytic virotherapy and is critical for long-term anti-tumor immunity.

Blood. Interventions and outcomes of multiple myeloma patients receiving salvage treatment after BCMA-directed CAR T therapy.

Cancer Cell. NKG2A and HLA-E define an alternative immune checkpoint axis in bladder cancer.

Cancer Immunology Research. Targeting macrophages with CAR T cells delays solid tumor progression and enhances antitumor immunity.

Cancer Discovery. Spatial positioning and matrix programs of cancer-associated fibroblasts promote T cell exclusion in human lung tumors.

Blood Advances. Sequencing T-cell redirection therapies leads to deep and durable responses in relapsed/refractory myeloma patients.

Clinical Lymphoma, Myeloma & Leukemia. High dimensional immune profiling of smoldering multiple myeloma distinguishes distinct tumor microenvironments.

Journal for Immunotherapy of Cancer. Integrated use of PD-1 inhibition and transarterial chemoembolization for hepatocellular carcinoma: evaluation of safety and efficacy in a retrospective, propensity score-matched study.

JCO Precision Oncology.  A three-gene signature predicts response to selinexor in multiple myeloma.

Cancer Cell. Augmentation of humoral and cellular immune responses after third-dose SARS-CoV-2 vaccination and viral neutralization in myeloma patients.

Nature Medicine. Neoadjuvant clinical trials provide a window of opportunity for cancer drug discovery.

Cell. Spatial CRISPS genomics identifies regulators of the tumor microenvironment.

The Lancet Gastroenterology & Hepatology. Neoadjuvant cemiplimab for resectable hepatocellular carcinoma: a single-arm, open-label, phase 2 trial.

Nature Reviews Immunology. Exhausted T cell phenotypes depend on TCR signal strength.

Journal for Immunotherapy of Cancer. Neoantigen vaccine-induced CD4 T cells confer protective immunity in a mouse model of multiple myeloma through activation of CD8 T cells against non-vaccine, tumor-associated antigens.

 

2023

Inflammatory Bowel Diseases. Cancer screening in patients with inflammatory bowel disease: don’t forget the anus!

The New England Journal of Medicine. Upadacitinib induction and maintenance therapy for Crohn’s disease.

The Journal of Clinical Investigation. Selective IgA2 deficiency in a patient with small intestinal Crohn’s disease.

Inflammatory Bowel Diseases. Acute Severe Ulcerative Colitis Is Associated With an Increased Risk of Acute Pouchitis.

Digestive Diseases and Sciences. Early Use of Biologics Reduces Healthcare Costs in Crohn's Disease: Results from a United States Population-Based Cohort.

Clinical Gastroenterology and Hepatology. Preclinical Serological Signatures are Associated With Complicated Crohn's Disease Phenotype at Diagnosis.

Gastroenterology. Anti-Integrin αvβ6 Autoantibodies Are a Novel Biomarker That Antedate Ulcerative Colitis.

2022

Gut. NOX1 is essential for TNFa-induced intestinal epithelial ROS secretion and inhibits M cell signatures.

Gastroenterology. Neutralizing anti-GM-CSF autoantibodies recognize posttranslational glycosylations on GM-CSF years prior to diagnosis and predict complicated Crohn’s Disease.

Cellular & Molecular Immunology. IFN-γ + cytotoxic CD4 + T lymphocytes are involved in the pathogenesis of colitis induced by IL-23 and the food colorant Red 40.

Nature Medicine. Ulcerative colitis is characterized by a plasmablast-skewed humoral response associated with disease activity.

The Lancet Gastroenterology & Hepatology. Treat to target with ustekinumab for Crohn’s disease.

Inflammatory Bowel Diseases. The multiple waves of COVID-19 in patients with inflammatory bowel disease: a temporal trend analysis.